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Abstract.  Immunogold labeling was used to localize 
the core protein of small dermatan sulfate proteoglycan 
(DS-PG)  on the surface of cultured human fibroblasts. 
At 4°C, DS-PG core protein was uniformly distributed 
over the cell surface. At 37°C,  gold particles either be- 
came rearranged in form of clusters or remained as- 
sociated with fibrils. Double-label immunocytochemis- 
try indicated the co-distribution of DS-PG core protein 
and fibronectin in the fibrils. In an enzyme-linked im- 
munosorbent assay, binding of DS-PG from fibroblast 
secretions and of its core protein to fibronectin oc- 
curred at pH 7.4 and at physiological ionic strength. 
Larger amounts of core protein than of intact pro- 
teoglycan could be bound.  Fibronectin peptides con- 
ruining either the heparin-binding domain near the 
COOH-terminal end or the heparin-binding NH2 ter- 
minus were the only fragments interacting with DS-PG 
and core protein.  Competition and replacement experi- 
ments with heparin and dermatan sulfate suggested the 
existence of adjacent binding sites for heparin and 
DS-PG core protein. It is hypothesized that heparan 
sulfate proteoglycans and DS-PG may competitively 
interact with fibronectin. 
T 
HE  small  dermatan  sulfate  proteoglycan  (DS-PG) ~ 
from human fibroblast secretions is a typical member 
of a possibly ubiquitous family of interstitial proteo- 
glycans that are characterized by the linkage of only a few ga- 
lactosaminoglycan chains or of even only one chain to a 
protein core with an Mr of '~40,000-50,000 (21). The galac- 
tosaminoglycan  chains may exhibit great differences in length 
and chemical composition. In cartilage, the chains are exclu- 
sively (22) or predominantly (41) of chondroitin sulfate-type 
but they contain a high proportion of L-iduronic acid in skin 
and sclera (8,  10). The small proteoglycan secreted by cul- 
tured human skin fibroblasts is a dermatan sulfate-type pro- 
teoglycan, too, since ,'~80% of its hexuronic acids are L-id- 
uronic acid (23).  The glycosaminoglycan  chains exhibited a 
mean Mr of 37,000. From cloned cDNA a molecular weight 
of 36,319 for the mature core protein was calculated. The se- 
quence includes three Ser-Gly dipeptides (26).  In bovine 
DS-PG the single glycosaminoglycan chain is linked to the 
serine residue at position 4 (7).  The two other Ser-Gly se- 
quences may become substituted by a second chain in some 
of the molecules (2, 26).  Additionally, either two or three 
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1.  Abbreviation used in this paper:  DS-PG, small dermatan sulfate pro- 
teoglycan from human skin fibmblasts. 
asparagine-bound oligosaccharides are present (15). There 
exists a second, less well characterized species of small DS- 
PG, the core protein of which is unrelated to that of fibroblast 
DS-PG (41). 
By ultrastructural studies DS-PGs have been shown to be 
located at the "d" band of type I collagen fbrils in unmineral- 
ized connective tissues (47, 48, 64). Tendon DS-PG and its 
core protein but not similar proteoglycans from cartilage or 
aorta inhibited fibrillogenesis of both type I and type II colla- 
gen (57).  DS-PG produced by human skin fibroblasts bound 
specifically to collagenous fibers of the extracellular matrix 
of the cells (14). It is therefore apparent that DS-PG exerts 
one of its biological functions in the extracellular matrix by 
interacting with collagen fibers. 
Indirect evidence raises the possibility that DS-PG is also 
associated with fibronectin. Immunofluorescence studies in- 
dicated that chondroitin sulfate and/or dermatan sulfate pro- 
teoglycans are components of the fibronectin-containing  peri- 
cellular matrix fibers of human fibroblasts (20).  Fibronectin 
added to the medium of cultured hamster fibroblasts could 
be chemically cross-linked to proteoglycans at the cell sur- 
face that contained galactosaminoglycan chains (35).  Vice 
versa, gold-decorated proteoglycans were bound to surface- 
associated  fibronectin  fibrils  of cultured  arterial  smooth 
muscle cells (59).  In contrast,  ferritin particles bound to 
chondroitin ABC lyase-degraded proteoglycan exhibited a 
distribution on  cell  surfaces  quite  different from that of 
fibronectin (19). 
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proteins present in extracellular matrices, basement mem- 
branes, and plasma. It consists of two disulfide-bonded poly- 
peptides, the primary structure of which varies in interstitial 
and  plasma  fibronectins  due  to  differential  splicing  of 
fibronectin pre-mRNA (25, 46). All fibronectin species ex- 
hibit pleiotropic functions, which are explained by the exis- 
tence of several  functional domains (see references 24, 56, 
61-63  for review)  and can be isolated by limited proteol- 
ysis. Two domains with high affinity and additional domains 
with lower affinity for heparin have been characterized (4, 
17, 34, 38, 50-53). The high affinity domains are located at 
the  NH2  terminal  and  between  the  cell-binding  and  the 
COOH-terminal fibrin-binding domains. Presently it is con- 
troversial whether or not heparin and heparan sulfate are 
bound at physiological pH and at physiological ionic strength 
(28, 50, 53, 55). It has also been shown that isolated heparin- 
binding domains may interact with dermatan sulfate, chon- 
droitin sulfate, and hyaluronate at low ionic strength (50). 
Other investigations, however, observed interactions in vitro 
between intact fibronectin and hyaluronate (29, 43, 63) or a 
chondroitin sulfate proteoglycan (33) under simulated physi- 
ological conditions. 
Here a co-distribution of fibronectin and DS-PG core pro- 
tein has been found in cultured fibroblasts by electron micro- 
scopic immunolocalization. Using an enzyme-linked immu- 
nosorbent assay,  the interaction of DS-PG and of its core 
protein with fibronectin and fibronectin peptides was inves- 
tigated. 
Materials and Methods 
lmmunochemical Reagents 
Rabbit antibodies against the DS-PG core protein were those used previ- 
ously (15) after affinity purification  (60).  They did not react with epitopes 
shared with other proteoglycans,  e.g., with the large glucuronic acid-rich 
proteoglycan from human fibroblasts. When fibroblasts were incubated for 
14 h in the presence of [3H]leucine (15) followed by chondroitinase ABC 
iyase digestion of the monolayer as described below, exclusively the core 
protein of the small DS-PG could be visualized upon subsequent immuno- 
precipitation,  SDS PAGE, and fluorography (15). The production of mono- 
clonal antibodies to DS-PG core protein (LN1, LN3, LN4) will be described 
in detail elsewhere.  Briefly, BALB/c mice were immunized with partially 
purified  DS-PG from fibroblast  secretions.  Lymph node and spleen cells 
were fused with the myeloma cell line X63-Ag8.653. Hybrid cells respon- 
sible for the production of anti-DS-PG antibodies were identified  by an 
ELISA  screening as described below and subcloned several times by the 
method of limiting dilution.  Established  clones were grown in KC-2000 
medium (KC Biological,  Raunheim, FRG). Antibodies were purified (6) by 
chromatography  on  CM-Trisacryl  (LKB  Instrument,  G~felfiog,  FRG). 
They could be distinguished by a different size of their heavy chains, but 
they  all belonged to subclass  IgG~. LN1  recognized  an epitope  near the 
glycosaminoglycan  attachment site,  whereas LN3  and LN4  bound to a 
carbohydrate-free  peptide  of Mr  17,000. Epitopes  were  localized  by im- 
munochemical staining of peptides obtained by limited digestion of DS-PG 
and DS-PG core protein, respectively, with staphylococcal serine proteinase 
V8  (36)  followed by SDS  PAGE (18, 27) and electrophoretic  transfer to 
nitrocellulose  paper (3).  Rabbit antiserum to human fibronectin was pur- 
Figure 1.  Silver stain of fibronectin peptides after polyacrylamide 
gel electrophoresis in the presence of SDS (total acrylamide con- 
centration 12.5%).  Lane A, peptide Tc 31; lane B, peptide Ca 70; 
lane C, peptide Ca 140; lane D, peptide Tc 66; lane E, peptide Tc 
33; lane F, peptide Cht 125. See text and Fig.  8 for further details. 
chased from Calbiochem (Frankfurt, FRG), goat anti-rabbit IgG from Bio- 
Rad  (Munich, FRG),  and rabbit anti-mouse IgG,  peroxidase  conjugate, 
from Sigma (Deisenhofen,  FRG). 
Materials 
DS-PG was prepared from spent media of human skin fibroblasts cultured 
in serum-free  media as described previously  (15). It was stored  frozen  in 
0.1% (vol/vol) Triton X-100 at concentrations greater than 0.5 mg/ml.  Im- 
mediately before use core protein was obtained by incubating the stock solu- 
tion of DS-PG with chondroitin ABC lyase (EC 4.2.2.4; Seikagaku Kogyo, 
Tokyo, Japan;  1 U/ml) in enriched Tris/acetate  buffer (45) for 2 h at 37°C 
in the presence of 0.1 M 6-aminohexanoic  acid, 10 mM EDTA, 5 mM ben- 
zamidinium hydrochloride,  and 10 mM N-ethylmaleimide. 
Fibronectin from human serum was obtained from Behring-Werke (Mar- 
burg,  FRG)  and purified  to 97%  purity by affinity chromatography  on a 
gelatin-Sepharose  4B (Pharmacia, Uppsala, Sweden) column as described 
(44). Purified material was dialyzed against 50 mM Tris/HCl buffer, pH 7.5, 
containing 3 mM NAN3, and stored at 4°C.  Fibronectin peptides  were pre- 
pared according to published procedures  (37, 38, 49, 54).  Shortly, an NH2- 
terminal Mr 70,000 heparin-binding peptide,  Ca 70,  and an adjacent Mr 
40,000  peptide,  Ca  140, representing  the central part of the fibronectin 
subunit chains, were isolated from an early digest performed with cathepsin 
D  (EC  3.4.23.5;  Sigma).  Chromatography  on  a  heparin-Sepharose 4B 
column yielded a fraction of medium binding strength containing the two 
fragments, which were separated by gel filtration on Ultrogei AcA 44 (LKB, 
Stockholm). Ca 70 was further purified on gelatin-Sepharose  4B. The prepa- 
ration contained additionally  a gelatin-binding 42-kD fragment generated 
by  further degradation.  A  stronger binding fraction from the heparin- 
Sepharose  step  contained another Mr  140,000 fragment comprising two 
disulfide-linked  peptide chains from the COOH-terminus of each subunit. 
It was treated with trypsin (EC 3.4.21.4;  Sigma) before rechromatography 
on heparin-Sepharose 4B. A nonbinding fragment, Tc 31, located close to 
the COOH-terminus of the longer subunit chain of plasma fibronectin, was 
collected  and the heparin-binding fragments  Tc 66 and Tc 33 were eluted 
and separated  from each other by gel filtration on Ultrogel AcA 44. Tc 31 
Figure 2. Surface replica of a fibroblast treated with chondroitin ABC lyase before incubation with rabbit anti-human-DS-PG antibodies 
followed by gold-labeled (12 nm) goat anti-rabbit IgG. (a) The gold particles are randomly distributed both on the plasma membrane surface 
(PS) and the bottom of the culture dish (B) at 4°C.  (b and c) When chondroitin ABC lyase-treated cells incubated with rabbit anti-hu- 
man-DS-PG antibodies and gold-labeled (12 run) anti-rabbit IgG at 4°C were kept at 37°C for 1 h, the gold label on the plasma membrane 
surface (PS) was observed primarily in clusters, whereas gold particles on the bottom (B) of the culture dish (b) and those associated 
with fibrils (F) on the cell surface did not participate in the clustering process (c).  Bars:  (a and b) 2  lxm; (c)  1 lain. 
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alternative cleavage site. The slightly heterogeneous fragment Tc 33 repre- 
sents the main heparin-binding domain of the longer subunit chain, whereas 
Tc 66 contains the beparin-binding and the subsequent nonbinding domain 
of the shorter subunit chain. Digestion of fibronectin with chymotrypsin 
(EC 3.4.21.1;  Sigma) gave rise to a peptide Cht 125, which differed from 
Ca 140 by lacking a basic NH2-terminal domain. It was isolated by chro- 
matography of the digest on heparin-Sepharose 4B followed by Ultrogel 
AcA 44. The positions of the peptides are shown schematically in Fig. 8. 
The purity of the fragments is indicated in Fig.  1. 
Enzyme-linked Immunosorbent Assay 
The interaction of fibronectin and of peptides derived therefrom with DS- 
PG and DS-PG core protein was studied by a modification of the procedure 
of Engvall and Perlmann (12). Generally, 50 Ixl of ligand solutions were al- 
lowed to react for 90 min at 37"C. Washing steps were performed at ambient 
temperature using 200  ~tl of PBS, pH  7.4,  containing 0.1% (vol/vol) of 
Tween 20  (buffer A).  Microtiter plates (Nunc-immuno plates II,  Nunc, 
Wiesbaden, FRG) were coated with fibronectin or fibronectin peptides (10 
i.tg/ml) dissolved in 0.1 M Tris/HC1 buffer, pH 7.4, containing 50 mM NaCI 
(buffer B). After three washing cycles unspecific binding was quenched by 
incubation with 3 % (wt/vol) BSA in buffer A, followed by four washing 
steps. Increasing concentrations of DS-PG or of its core protein, dissolved 
in buffer B, were then added. The plates were washed again three times be- 
fore incubation with one or with an equimolar mixture of the monoclonal 
antibodies against the DS-PG core protein (125 Ixg/mi). To reduce unspecific 
background, washing steps were followed by treatment with 3 % BSA in 
buffer A. The wells were rinsed four times and incubated with second anti- 
body, rabbit anti-mouse IgG,  conjugated to peroxidase (dilution  1:1,000 
with buffer A). The wells were washed five times and incubated with sub- 
strate solution (200 lxl of I mM 2,2'-azinobis(3-ethylbenzthiazolinesulfonic 
acid) and 37 ~tM H202 in 50 mM sodium citrate, pH 4.0). Color develop- 
ment was stopped by adding 50 ~tl 10 mM NAN3, and the absorbance at 410 
nm was measured with a Multiscan photometer (Flow Laboratories, Bonn, 
FRG). Testing for monoclonal antibodies was performed analogously. The 
wells were coated with DS-PG core protein (5 ~g/ml). Blocking of reacting 
sites was performed by incubation with 1% (wt/vol) gelatin in 0.1% SDS. 
Electron Microscopy and Immunolocalization 
Gold particles of ,'~7-nm diam were prepared by reduction of chloroauric 
acid with tannic acid as described (32) and saturated with protein A (Sigma) 
according to Roth et al. (42). Gold particles of 12-nm diam were prepared 
by reduction of chloroauric acid with sodium citrate (13) and coated with goat 
anti-rabbit IgG as described (11) or with protein A. The stability of the con- 
jugates was tested by addition of 10 % NaC1. All preparations were routinely 
examined by negative staining before use and discarded if unsatisfactory. 
Negative staining was performed by placing a Formvar-coated grid for 1-5 
rain on a drop of a diluted sample of  the gold conjugate and then transferring 
it to a drop of 2%  (wt/vol) uranyl acetate, pH 3.5,  for 1-5  min. 
Indirect immunocytochemistry  was used to detect DS-PG and fibronectin 
on the surface of cultured human fibroblasts. Cells from healthy juvenile 
donors were maintained in culture as described (5) and used after the fifth 
to twelfth passage.  1 d  after plating the cells in 5.5-cm  2 Falcon plastic 
dishes, medium was removed, and the cell layer was incubated for 30 rain 
at 37°C with 50 mU chondroitin ABC lyase (Seikagaku  Kogyo, Tokyo, Ja- 
pan) in 0.7 mt of Hanks' balanced salt solution containing 1% BSA. All sub- 
sequent steps were performed at 4°C. Nonspecific background labeling was 
minimized by preincubating the cells in 1% BSA/PBS, pH 7.4,  for 15-30 
min. Then, rabbit anti-human DS-PG antibodies (1 lag/ml) or rabbit anti- 
human fibronectin antibodies (22 ixg/ml),  both in 1% BSA/PBS, were al- 
lowed to react for 60 min before the cells were washed three times for 5 
min each with 1% BSA/PBS. For visualization of DS-PG core protein, cells 
were incubated for 30-60 rain with gold-labeled goat anti-rabbit IgG (1:30 
dilution with 1%  BSA/PBS). An analogous incubation with gold-labeled 
protein A was done for staining of fibronectin. In double-labeling experi- 
ments the reactions for immunocbemical labeling of DS-PG core protein 
were performed first. The protein A binding sites of the goat anti-rabbit 
IgG-gold complexes were then blocked by incubating the cells for 30 min 
with uncoupled protein A (4 ~tg/ml PBS) before fibronectin labeling. Label- 
ing was terminated by three 5-min washes with PBS. The cells were then 
fixed for 30 min in the culture dish with a formaldehyde/glutaraldehyde  fixa- 
tive and subjected to surface replication. In all experimental series, the 
specificity of the immunostaining was controlled by omitting one or both 
of the primary antibodies. In case of staining of DS-PG core protein, addi- 
tional studies were performed by warming up immunogold-labeled cells to 
37°C for 15-60 rain. 
For surface replication, fixed fibroblasts were dehydrated and subjected 
to critical point or air drying. The bottom of the dish with the attached cells 
was cut in 1-cm  2 pieces using a soldering iron. Platinum-carbon replicas 
of the surface of the cell monolayers were made in a Balzers BA 300 freeze- 
etching apparatus (Balzers, Lichtenstein), equipped with an electron gun 
evaporator and a quartz crystal thickness monitor. Replicas were obtained 
by shadowing the cell surface with platinum-carbon at an angle of 38* fol- 
lowed with carbon at 90 ° . 
For post-embedding immunocytochemical labeling of fibronectin, the 
cells were fixed for 30 min at 4°C in 3% (vol/vol) paraformaldehyde and 
3% (vol/vol) glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4. The speci- 
mens were washed twice with cacodylate buffer, dehydrated in an ascending 
series ofdimethyl formamide, and embedded in Lowicryl K4M as described 
(58).  All subsequent steps were carried out at ambient temperature. The 
grids  were  sequentially  placed  with  their  section side down on  10-1xl 
droplets placed on wax sheets. Pretreatment with 0.02 M glycine in PBS, 
pH 8.2, and/or with 1% BSA/PBS, pH 7.4, for 15 min followed by two 5-min 
washes with PBS, pH 7.4, was performed to block nonspecific binding sites 
and to quench aldehydes present on the section surface. Reactions with pri- 
mary antibodies and gold-labeled protein A were performed analogously to 
surface staining. Labeled grids were finally rinsed with water and stained 
with aqueous  uranyl  acetate  and  lead citrate.  All electron microscopic 
studies were performed with a Philips EM 201  at 60 kV. 
Other Methods 
Uronic acids (1) and protein (30)  were quantitated as described. 1.3 ~tmol 
of hexuronic acid is equivalent to 1 mg of DS-PG. Polyacrylamide gel elec- 
trophoresis in the presence of SDS followed by silver staining (31) was per- 
formed by a modification (18) of the procedure of Laemmli (27). 
Results 
Immunolocalization of  DS-PG and Fibronectin 
With the aid of platinum-carbon replicas,  large continuous 
areas of the plasma membrane  of cultured fibroblasts  can 
be visualized in electron micrographs.  The cell  surface  is 
smooth, interrupted only by few microvilli or fibrillar struc- 
tures,  whereas  numerous peripheral  processes  of variable 
length stretch from the cell border. 
When intact unfixed cells were treated with chondroitin 
ABC lyase followed by immunostaining of DS-PG core pro- 
tein at 4°C, an intense labeling by gold particles could be ob- 
served.  The  gold  particles  occur  singly,  form  small  ag- 
gregates, or are aligned in short rows of three to five particles 
Figure 3. (a) Surface replica ofa fibroblast incubated with rabbit anti-human fibronectin antibodies followed by gold-labeled (12 nm) protein 
A. The gold label is exclusively associated with a fibrillar network (F) on the plasma membrane surface (PS). (b) Thin section ofa Lowicryl 
K4M embedded fibroblast incubated with rabbit anti-human fibronectin antibodies followed by gold-labeled (12 nm) protein A. The gold 
particles are found over extracellular fibrils (F) confirming that fibronectin is a major component of the extracellular matrix. (c) Surface 
replica of a fibroblast sequentially labeled for DS-PG core protein by rabbit anti-human-DS-PG antibodies and gold-labeled goat anti-rabbit 
antibodies and for fibronectin by rabbit anti-human fibronectin antibodies and gold-labeled protein A.  A  co-distribution of fibronectin 
(7-nm-diam gold) with DS-PG core protein (12-nm-diam gold) can be observed. PS, plasma membrane surface. F, fibril. Bars: (a)  1 lain; 
(b and c) 0,5  I.tm. 
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the bottom of the culture dish (Fig. 2 a). In controls in which 
the  primary  antibodies  were  omitted,  only  a  negligible 
amount of label was found.  1.0- 
When cells incubated with primary antibodies and gold- 
labeled anti-rabbit IgG at 4°C were warmed up to 37°C,  the 
gold particles were rearranged into clusters within  15 min  E  c  0.8- 
(Fig. 2 b). However, gold particles associated with fibrils on  o 
the cell surface (and the panicles on the bottom of the culture  .,e 
dish) did not participate in the clustering process (Fig. 2 c).  o  ~  0.6- 
Fibroblasts incubated with anti-fibroneetin antibodies fol-  ,- 
lowed by gold-labeled protein A exhibited a fibrillar labeling  ,.-B 
pattern in surface replicas. As shown in Fig.  3 a, immuno-  o  O.4- 
reactivity  was  associated  exclusively  with  a  fibrillar  net-  ,< 
work. The bottom of the culture dish exhibited only a small 
amount of label, whereas the peripheral processes traversing 
the  bottom  could  be  intensively  stained.  Post-embedding 
immunocytochemistry of thin  sections also confirmed the 
finding that fibronectin is a major component of the extracel- 
lular fibrillar matrix (Fig.  3 b). 
Double-label immunocytochemistry was used to study the 
distribution of DS-PG core protein in relation to the distribu- 
tion of fibronectin. A co-distribution of fibronectin with DS- 
PG core protein was found (Fig.  3 c). However, DS-PG of 
fibrillar localization tended to exhibit a more punctate label- 
ing than that of fibronectin. 
In Vitro Incubation of  l~'bronectin with DS-PG 
and Its Core Protein 
Enzyme-linked immunosorbent assays were performed to in- 
vestigate the interaction of fibronectin with DS-PG in more 
detail. Advantage was taken by the availability of monoclonal 
antibodies that specifically recognize epitopes on the core 
protein of DS-PG. It is shown in Fig. 4 that fibronectin im- 
mobilized on the bottom of polystyrene wells can bind DS- 
PG as well as its core protein in a  saturable manner.  The 
enzyme-linked  second  antibody  produced  greater  absor- 
bance when core protein instead of native DS-PG was used 
as  a  ligand.  Use  of [3H]leucine-labeled  DS-PG  and  core 
protein, respectively, as a ligand followed by solubilization 
of bound material with papain (8 mg of enzyme in 200  ~tl 
of 0.1 M sodium acetate, pH 6.5, containing 5 mM EDTA and 
5 mM cysteine, 2 h at 37°C) revealed that up to 2.2 ng of DS- 
PG and up to a 2.5-fold equivalent of core protein could be 
O~ 
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..........  o 
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Figure 5.  Ionic  strength- and pH-dependent  interaction  between 
fibronectin  and  either  DS-PG  (o  o)  or  its  core  protein 
(o -  -  -  o). The DS-PG concentration was 10 Ixg/ml. 
bound per well. Comparing these values with the absorbance 
obtained in the standard assay it was calculated that in the 
case of fibronectin-bound ligands the monoclonal antibodies 
recognized  native  DS-PG  1.5  times  better  than  the  core 
protein. 
The interaction between fibronectin and DS-PG was de- 
pendent on pH and ionic strength (Fig. 5). Optimal binding 
of both proteoglycan and core protein occurred at pH 5.0. At 
pH 8.0 binding of core protein was almost negligible, where- 
as DS-PG reacted similarly as at pH 7.4 (result not shown). 
Binding of DS-PG and of its core protein to fibronectin was 
facilitated by low ionic strength but still occurred at physio- 
logical ionic strength. 
As shown above, greater quantities of core protein than of 
intact DS-PG could be bound per fibronectin-coated well. 
This could be explained by the existence of additional bind- 
ing sites for glycosaminoglycan-free core protein. Preincu- 
bation of fibronectin with native DS-PG to saturate all DS- 
E 
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DS-PG (l~/ml)  or core ~oteln 
O  O 
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Figure 4. Enzyme-linked immunosorbent 
assay using fibronectin-coated wells and 
either  DS-PG  (o  o) or equivalent 
amounts of its core protein (o -  -  -  o) 
as ligands. In A, the wells were coated 
with  10 ~tg/ml, in B with 20 I.tg/ml of 
fibronectin. 
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Figure 6. Binding  capacity of fibronectin  for DS-PG and its core 
protein.  In A,  fibronectin-coated  wells  were  preincubated  with 
DS-PG (10 rtg/ml) before a second incubation with the proteoglycan 
(o  o) or equivalent amounts of its core protein (o -  -  -  o). In 
B, preincubation was with core protein equivalent  to 10 Ixg/ml of 
DS-PG followed by incubation with proteoglycan (e  e) or core 
protein (e -  -  -  e). 
binding domain near the COOH-terminal end of the mole- 
cule exhibit saturable binding properties for DS-PG and its 
core protein.  Peptides containing the NH2-terminal heparin- 
binding domain also interacted with these ligands albeit less 
efficiently. Almost no interaction was found when peptides 
containing  the  cell-  and  collagen-binding  domains  were 
tested. 
Discussion 
Indirect immunocytochemistry at the electron microscopic 
level established the dual localization of DS-PG core protein 
on the surface of cultured human skin fibroblasts.  Immune 
reactive material was either able to form clusters at 37°C or 
was  associated  with  fibrils  and  did  not  participate  in  the 
clustering process. At least some of the mobile core protein 
is considered to be destined for receptor-mediated endocyto- 
sis because endocytosis of DS-PG involves recognition of its 
protein moiety (16). Double-label immunocytochemistry in- 
dicated  that  immobile  core  protein  was  associated  with 
fibronectin  fibrils.  DS-PG core protein,  however,  was  not 
smoothly distributed  along the fibrils but exhibited a punc- 
tate staining pattern. 
Enzyme-linked immunosorbent assays supported the sug- 
gestion of an interaction of fibronectin with  intact DS-PG 
as well  as its glycosaminoglycan-free core protein.  Larger 
quantities of core protein than of DS-PG could be bound to 
a given amount of fibronectin.  However, none of the fibro- 
nectin  peptides  tested  exhibited  binding  properties  exclu- 
sively for core protein.  This might indicate that more core 
PG binding sites followed by a second incubation with core 
protein made the binding of additional core protein (Fig. 6) 
possible.  In the  converse  experiment,  preincubation  with  _~ 
core protein followed by a  second incubation with DS-PG,  o  100- 
no additional binding was observed. The interaction between 
core protein and fibronectin seemed at variance with the as-  u 
sumption  of a  direct  involvement  of one  of the  heparin-  ~ .~  s0- 
!  binding domains of the fibronectin molecule in core protein  o  e 
binding.  Preincubation of fibronectin with either heparin or  "*  o  ° 
protein-free dermatan  sulfate exhibited no effect on subse-  ,7 ~  60- 
quent DS-PG or core protein binding.  However, when DS-  c  o 
PG or core protein were incubated together with protein-free  40- 
dermatan sulfate or heparin,  binding of the proteoglycan as  _8 
well as of the core protein was strongly inhibited,  heparin  <  o  >,. 
being more inhibitory than dermatan  sulfate (Fig.  7).  This  ~  20- 
effect was not due to an unspecific effect of the polyanions  o 
since in the presence of chondroitin-4-sulfate only 10% inhi-  ~v 
bition could be observed. Incubation with the glycosamino- 
glycans (100 rtg/ml) after an interaction between fibronectin 
and either DS-PG or core protein had been allowed to occur, 
led to a replacement of maximally 25 % of  bound DS-PG and 
15 % of bound core protein.  No further desorption was ob- 
served when the concentration of  heparin or dermatan sulfate 
was increased to 500  rtg/ml. 
In Vitro Incubation of l~bronectin Peptides 
with DS-PG and Its Core Protein 
For further investigations of the fibronectin domains that in- 
teract with DS-PG and its core protein,  various fibronectin 
peptides were prepared, the binding properties of which have 
been characterized previously (37,  38, 49,  54).  It is shown 
in Fig.  8 that fibronectin peptides that contain the heparin- 
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Figure 7. Influence of heparin and dermatan sulfate on binding of 
DS-PG or its core protein to fibronectin.  All values are referred to 
the difference  in absorbance at 410 nm between  incubations  with 
DS-PG or core protein without any additions  of free glycosamino- 
glycans and the blank value.  In assay  1, fibronectin-coated  wells 
were incubated  with protein-free  glycosaminoglycans (100 ~tg/ml) 
for 90 min at 37°C before incubation with DS-PG (10 rtg/ml) or an 
equivalent amount of its core protein.  Assay 2 was performed as as- 
say 1 except that glycosaminoglycans  were also present during incu- 
bation with DS-PG or core protein.  In assay  3,  incubation with 
glycosaminoglycans was performed under the conditions of assay 
1 but after preincubation with DS-PG or core protein. 
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Figure 8. Binding of DS-PG (solid lines) and its core protein (bro- 
ken lines) to fibronectin peptides.  10 gg per ml of the respective 
peptides were used for coating. (A) Peptides Cht  125 (o) and Tc 
31 (o); (B) peptide Ca 140; (C) peptides Ca 70 (,x), Tc 33 (o), and 
Tc 66 (o). The position of the peptides is shown schematically at 
the bottom of the figure. 
protein than DS-PG molecules can interact with the respec- 
tive  domains  on  the  fibronectin  molecule.  Alternatively, 
some of the binding sites could be accessible only for the 
small core protein after immobilization of fibronectin to the 
plastic dish. 
The influence of ionic strength and pH on binding of DS- 
PG and its core protein to fibronectin implies that the interac- 
tion is electrostatic and suggests that histidine residues of the 
fibronectin  molecule might be involved in  binding.  Con- 
sidering  the  observation  that  exclusively  heparin-binding 
fibronectin  peptides  participated  in  this  interaction,  one 
could postulate that heparin- and core protein-binding sites 
are identical. However, unsubstituted core protein is very ba- 
sic (pH 9.8), and it does not appear very likely that the single 
acidic region at the NH2 terminus (26) could create a struc- 
ture that mimics heparin. The results of co-incubation with 
and replacement by heparin and protein-free dermatan sul- 
fate (Fig. 7) would rather suggest the existence of adjacent 
binding sites for heparin and DS-PG core protein. Steric hin- 
drance of DS-PG core protein binding would be possible un- 
der co-incubation conditions, whereas only minor amounts 
of bound core protein could be replaced by an excess of poly- 
saccharide. It is obvious that additional assay systems resem- 
bling possible in vivo situations are required to study the in- 
teractions between fibronectin and  DS-PG core protein in 
greater detail. 
It had been shown recently that DS-PG bound completely 
to fibronectin-Sepharose columns and inhibited the capacity 
of fibroblasts to  adhere  to  a  fibronectin  substratum  (40). 
Chondroitin  sulfate proteoglycans from cartilage exhibited 
only a marginal effect in the latter assay. 
On the contrary, heparan sulfate proteoglycans play a di- 
rect role in forming adhesive bonds on fibronectin (39).  In 
fibroblasts, heparan sulfate binding of fibronectin acted in a 
cooperative manner with the cell-binding domain of fibro- 
nectin (9).  Thus,  if heparan sulfate proteoglycans and DS- 
PGs interact with adjacent binding sites on the fibronectin 
molecule and  if the  binding  of one  proteoglycan  species 
influences the binding of the other one, both proteoglycans 
could participate in the regulation of cellular functions in a 
competitive manner. Further studies are required to test this 
hypothesis. 
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